Case Report: Personalized management of HER2-positive breast cancer with advanced nodal disease during pregnancy: a clinical case and review.
Saved in:
| Title: | Case Report: Personalized management of HER2-positive breast cancer with advanced nodal disease during pregnancy: a clinical case and review. |
|---|---|
| Authors: | Gullotta C; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Diseases, Hospital Clinic de Barcelona, Barcelona, Spain.; Department of Oncology, Fondazione Policlinico Universitario Campus Bio-Medico di Roma, Rome, Italy., Walbaum B; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Diseases, Hospital Clinic de Barcelona, Barcelona, Spain.; Department of Hematology Oncology, Pontificia Universidad Católica de Chile, Santiago, Chile.; Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.; Facultat de Medicina i Ciencias de la Salut, Universitat de Barcelona (UB), Barcelona, Spain., Seguí E; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Diseases, Hospital Clinic de Barcelona, Barcelona, Spain.; Facultat de Medicina i Ciencias de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Breast Oncology Program, Dana-Farber Cancer Institute, Boston, MA, United States., López M; Facultat de Medicina i Ciencias de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.; Department of Obstetrics and Gynecology and Neonatology, Hospital Clinic of Barcelona, Barcelona, Spain., Mension E; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Facultat de Medicina i Ciencias de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.; Department of Obstetrics and Gynecology and Neonatology, Hospital Clinic of Barcelona, Barcelona, Spain., Cebrecos I; Facultat de Medicina i Ciencias de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.; Department of Obstetrics and Gynecology and Neonatology, Hospital Clinic of Barcelona, Barcelona, Spain., Molla M; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Facultat de Medicina i Ciencias de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.; Radiation Oncology Department, Hospital Clinic Barcelona, Barcelona, Spain., Oses G; Facultat de Medicina i Ciencias de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.; Radiation Oncology Department, Hospital Clinic Barcelona, Barcelona, Spain., Bargalló X; Facultat de Medicina i Ciencias de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.; Department of Radiology, Hospital Clinic, Barcelona, Spain., Ganau-Macias S; Facultat de Medicina i Ciencias de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.; Department of Radiology, Hospital Clinic, Barcelona, Spain., Sanfeliu E; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Facultat de Medicina i Ciencias de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.; Pathology Department, Hospital Clínic de Barcelona, Barcelona, Spain., Braso-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Diseases, Hospital Clinic de Barcelona, Barcelona, Spain.; Molecular Biology CORE (CDB), Hospital Clínic de Barcelona, Barcelona, Spain., Muñoz M; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Diseases, Hospital Clinic de Barcelona, Barcelona, Spain.; Facultat de Medicina i Ciencias de la Salut, Universitat de Barcelona (UB), Barcelona, Spain., Prat A; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Diseases, Hospital Clinic de Barcelona, Barcelona, Spain.; Facultat de Medicina i Ciencias de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.; Reveal Genomics, Barcelona, Spain.; Institute of Oncology (IOB), Hospital Quironsalud, Barcelona, Spain., Vidal M; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Diseases, Hospital Clinic de Barcelona, Barcelona, Spain.; Facultat de Medicina i Ciencias de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.; Institute of Oncology (IOB), Hospital Quironsalud, Barcelona, Spain., Adamo B; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Cancer Institute and Blood Diseases, Hospital Clinic de Barcelona, Barcelona, Spain.; Facultat de Medicina i Ciencias de la Salut, Universitat de Barcelona (UB), Barcelona, Spain. |
| Source: | Frontiers in oncology [Front Oncol] 2026 Jan 19; Vol. 15, pp. 1672751. Date of Electronic Publication: 2026 Jan 19 (Print Publication: 2025). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
